• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绿茶补充剂对肥胖的影响:一项随机对照试验的系统评价和剂量反应荟萃分析。

The effect of green tea supplementation on obesity: A systematic review and dose-response meta-analysis of randomized controlled trials.

机构信息

Department of Endocrinology, Jinan Municipal Hospital of Traditional Chinese Medicine, Jinan City, Shandong Province, China.

Department of Internal Medicine, Jinan Central Hospital, Jinan, Shandong Province, China.

出版信息

Phytother Res. 2020 Oct;34(10):2459-2470. doi: 10.1002/ptr.6697. Epub 2020 May 5.

DOI:10.1002/ptr.6697
PMID:32372444
Abstract

The effects of green tea (GT) in obese subjects have been evaluated in different studies, but no consensus has been obtained due to the heterogeneity of the results. The dosage, the type of extract, and the duration of the intervention are the main contributors to the heterogeneity of the results. Therefore, the present systematic review and meta-analysis aimed to evaluate the efficacy and dose-response relationship of GT. Several databases were searched from inception to September 2019 to identify clinical trials that examined the influence of GT supplements on obesity indices in humans. Combined results using the random-effects model indicated that body weight (WMD: -1.78 kg, 95% CI: -2.80, -0.75, p = .001) and body mass index (BMI) (WMD: -0.65 kg/m , 95% CI: -1.04, -0.25, p = .001) did change significantly following GT administration. The reduction in waist circumference (WC) after GT consumption was significant in subjects in trials employing GT ≥800 mg/day (WMD: -2.06 cm) and with a treatment duration <12 weeks (WMD: -2.39 cm). Following the dose-response evaluation, GT intake did alter body weight, with a more important reduction when the GT dosage was <500 mg/day and the treatment duration was of 12 weeks. The results of present meta-analysis study support the use of GT for the improvement of obesity indices. Thus, we suggest that the use of GT can be combined with a balanced and healthy diet and regular physical exercise in the management of obese patients.

摘要

绿茶(GT)对肥胖人群的影响已在不同的研究中进行了评估,但由于结果的异质性,尚未得出共识。剂量、提取物类型和干预持续时间是导致结果异质性的主要因素。因此,本系统评价和荟萃分析旨在评估 GT 的疗效和剂量反应关系。从开始到 2019 年 9 月,我们检索了多个数据库,以确定检查 GT 补充剂对人体肥胖指数影响的临床试验。使用随机效应模型对合并结果进行分析表明,体重(WMD:-1.78kg,95%CI:-2.80,-0.75,p=0.001)和体重指数(BMI)(WMD:-0.65kg/m,95%CI:-1.04,-0.25,p=0.001)在服用 GT 后确实发生了显著变化。在采用 GT≥800mg/天(WMD:-2.06cm)和治疗持续时间<12 周(WMD:-2.39cm)的试验中,GT 消耗后腰围(WC)的减少具有统计学意义。在进行剂量反应评估后,GT 摄入量确实改变了体重,当 GT 剂量<500mg/天且治疗持续时间为 12 周时,体重的减轻更为明显。本荟萃分析研究的结果支持使用 GT 来改善肥胖指数。因此,我们建议在肥胖患者的管理中,可以将 GT 的使用与均衡健康的饮食和定期体育锻炼相结合。

相似文献

1
The effect of green tea supplementation on obesity: A systematic review and dose-response meta-analysis of randomized controlled trials.绿茶补充剂对肥胖的影响:一项随机对照试验的系统评价和剂量反应荟萃分析。
Phytother Res. 2020 Oct;34(10):2459-2470. doi: 10.1002/ptr.6697. Epub 2020 May 5.
2
The effect of green tea supplementation on the anthropometric outcomes in overweight and obese women: a time and dose-response meta-analysis of randomized controlled trials.绿茶补充剂对超重和肥胖女性人体测量学结局的影响:随机对照试验的时间和剂量反应荟萃分析。
Crit Rev Food Sci Nutr. 2024;64(28):10138-10147. doi: 10.1080/10408398.2023.2220796. Epub 2023 Jun 10.
3
The effect of green-coffee extract supplementation on obesity: A systematic review and dose-response meta-analysis of randomized controlled trials.绿咖啡豆提取物补充剂对肥胖的影响:随机对照试验的系统评价和剂量反应荟萃分析。
Phytomedicine. 2019 Oct;63:153018. doi: 10.1016/j.phymed.2019.153018. Epub 2019 Jul 5.
4
The effect of green coffee extract supplementation on anthropometric measures in adults: A comprehensive systematic review and dose-response meta-analysis of randomized clinical trials.绿咖啡提取物补充剂对成年人人体测量学指标的影响:随机临床试验的综合系统评价和剂量反应荟萃分析。
Complement Ther Med. 2020 Jun;51:102424. doi: 10.1016/j.ctim.2020.102424. Epub 2020 May 5.
5
The effect of berberine supplementation on obesity indices: A dose- response meta-analysis and systematic review of randomized controlled trials.黄连素补充剂对肥胖指数的影响:一项随机对照试验的剂量反应荟萃分析和系统评价。
Complement Ther Clin Pract. 2020 May;39:101113. doi: 10.1016/j.ctcp.2020.101113. Epub 2020 Feb 1.
6
Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials.白藜芦醇补充剂对肥胖指标有显著影响:一项随机对照试验的系统评价和剂量反应荟萃分析。
Obes Rev. 2019 Mar;20(3):487-498. doi: 10.1111/obr.12775. Epub 2018 Dec 5.
7
Alpha-lipoic acid supplementation significantly reduces the risk of obesity in an updated systematic review and dose response meta-analysis of randomised placebo-controlled clinical trials.α-硫辛酸补充剂在更新的系统评价和随机安慰剂对照临床试验的剂量反应荟萃分析中显著降低肥胖风险。
Int J Clin Pract. 2020 Jun;74(6):e13493. doi: 10.1111/ijcp.13493. Epub 2020 Mar 26.
8
The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.姜黄素补充剂对非酒精性脂肪性肝病患者体重指数、体重和腰围的影响:系统评价和随机对照试验的剂量反应荟萃分析。
Phytother Res. 2020 Mar;34(3):464-474. doi: 10.1002/ptr.6542. Epub 2019 Dec 4.
9
The effects of psyllium supplementation on body weight, body mass index and waist circumference in adults: A systematic review and dose-response meta-analysis of randomized controlled trials.车前草补充剂对成年人体重、体重指数和腰围的影响:系统评价和随机对照试验的剂量反应荟萃分析。
Crit Rev Food Sci Nutr. 2020;60(5):859-872. doi: 10.1080/10408398.2018.1553140. Epub 2019 Mar 18.
10
The effect of subcutaneous dulaglutide on weight loss in patients with Type 2 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials.皮下注射度拉糖肽对 2 型糖尿病患者体重减轻的影响:随机对照试验的系统评价和荟萃分析。
Eur J Clin Invest. 2024 Apr;54(4):e14125. doi: 10.1111/eci.14125. Epub 2023 Nov 11.

引用本文的文献

1
Catechins and Human Health: Breakthroughs from Clinical Trials.儿茶素与人类健康:临床试验的突破
Molecules. 2025 Jul 25;30(15):3128. doi: 10.3390/molecules30153128.
2
Natural bioactive compounds and their mechanisms of action in the management of obesity: a narrative review.天然生物活性化合物及其在肥胖管理中的作用机制:一项叙述性综述
Front Nutr. 2025 Jun 26;12:1614947. doi: 10.3389/fnut.2025.1614947. eCollection 2025.
3
The role of tea in managing cardiovascular risk factors: potential benefits, mechanisms, and interventional strategies.
茶在管理心血管危险因素中的作用:潜在益处、机制及干预策略。
Front Nutr. 2025 Apr 24;12:1530012. doi: 10.3389/fnut.2025.1530012. eCollection 2025.
4
A Systematic Review on Important Risk Factors and Possible Involved Mechanisms of Medicinal Plants on Nonalcoholic Fatty Liver Disease.药用植物对非酒精性脂肪性肝病的重要危险因素及可能涉及机制的系统评价
Adv Biomed Res. 2025 Feb 28;14:20. doi: 10.4103/abr.abr_94_23. eCollection 2025.
5
Associations between green tea drinking and body mass index, serum lipid profile and prostate-specific antigen in a Ghanaian population: a cross-sectional study.加纳人群中饮用绿茶与体重指数、血脂谱和前列腺特异性抗原之间的关联:一项横断面研究。
BMC Nutr. 2025 Mar 14;11(1):55. doi: 10.1186/s40795-025-01039-9.
6
Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort.茶消费与肝脂肪变性和肝纤维化的关系:来自纵向RaNCD队列的研究结果
BMC Nutr. 2025 Mar 3;11(1):47. doi: 10.1186/s40795-025-01032-2.
7
Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential.表没食子儿茶素没食子酸酯(EGCG):药理特性、生物活性及治疗潜力
Molecules. 2025 Feb 1;30(3):654. doi: 10.3390/molecules30030654.
8
Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity.不当饮食通过腹部肥胖加剧代谢功能障碍相关脂肪性肝病。
Nutrients. 2024 Dec 5;16(23):4208. doi: 10.3390/nu16234208.
9
Effect of tea consumption on the development of hypertension, diabetes, and obesity: a bidirectional two-sample Mendelian randomization analysis.饮茶对高血压、糖尿病和肥胖症发生发展的影响:一项双向两样本孟德尔随机化分析
Front Nutr. 2024 Oct 31;11:1428445. doi: 10.3389/fnut.2024.1428445. eCollection 2024.
10
Overview of oxidative stress and inflammation in diabetes.糖尿病中氧化应激和炎症的概述。
J Diabetes. 2024 Oct;16(10):e70014. doi: 10.1111/1753-0407.70014.